VTS-K

DRUG2 trials

Conditions

AnalgesiaAnalgesics, Non-NarcoticAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalCentral Nervous System DepressantsDepressive SymptomsKetamineMajor Depressive Disorder

Phase 4

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

CompletedNCT05615948

Theresa Jacob, PhD, MPHAnalgesia, Analgesics, Non-Narcotic, Anti-Inflammatory Agents +10

Start: 2022-12-06End: 2024-05-17Updated: 2026-04-21

Unknown Phase

Analgesic Efficacy of Orally Administered VTS-K for Pain Management

CompletedNCT04702555

Antonios LikourezosPain, Acute

Start: 2021-01-08End: 2021-12-31Updated: 2022-04-08

VTS-K

Sponsors

Conditions

Phase 4

Unknown Phase